| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6711504
[patent_doc_number] => 20030171253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Methods and compositions relating to modulation of A20'
[patent_app_type] => new
[patent_app_number] => 10/125770
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 47713
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125770 | Methods and compositions relating to modulation of A20 | Apr 17, 2002 | Abandoned |
Array
(
[id] => 6846855
[patent_doc_number] => 20030166022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/124805
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 55084
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166022.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124805 | Compositions and methods for the therapy and diagnosis of breast cancer | Apr 14, 2002 | Issued |
Array
(
[id] => 690315
[patent_doc_number] => 07074601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Nucleozymes'
[patent_app_type] => utility
[patent_app_number] => 10/102094
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 6425
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102094 | Nucleozymes | Mar 18, 2002 | Issued |
Array
(
[id] => 6809083
[patent_doc_number] => 20030199022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells'
[patent_app_type] => new
[patent_app_number] => 10/095373
[patent_app_country] => US
[patent_app_date] => 2002-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34541
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199022.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095373 | Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells | Mar 10, 2002 | Issued |
| 09/913610 | Antisense Modulation of smad3 expression | Feb 28, 2002 | Abandoned |
Array
(
[id] => 7622176
[patent_doc_number] => 06977325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Plant promoter sequences and methods of use for same'
[patent_app_type] => utility
[patent_app_number] => 10/086062
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16306
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086062 | Plant promoter sequences and methods of use for same | Feb 27, 2002 | Issued |
Array
(
[id] => 6082447
[patent_doc_number] => 20020082237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Cationic polymers and lipids for the delivery of nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/084159
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11150
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084159 | Cationic polymers and lipids for the delivery of nucleic acids | Feb 27, 2002 | Abandoned |
Array
(
[id] => 6861643
[patent_doc_number] => 20030092651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Tissue-specific and target RNA-specific ribozymes'
[patent_app_type] => new
[patent_app_number] => 10/082973
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23439
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082973 | Tissue-specific and target RNA-specific ribozymes | Feb 25, 2002 | Issued |
Array
(
[id] => 6745853
[patent_doc_number] => 20030023036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/076622
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 54345
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20030023036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076622 | Compositions and methods for the therapy and diagnosis of breast cancer | Feb 12, 2002 | Issued |
| 09/958087 | Antisense modulation of p38 mitogen activated protein kinase expression | Feb 11, 2002 | Abandoned |
Array
(
[id] => 6710987
[patent_doc_number] => 20030170736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Methods and compositions for producing neural progenitor cells'
[patent_app_type] => new
[patent_app_number] => 10/059273
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15549
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170736.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059273 | Methods and compositions for producing neural progenitor cells | Jan 30, 2002 | Abandoned |
Array
(
[id] => 256075
[patent_doc_number] => 07575743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells'
[patent_app_type] => utility
[patent_app_number] => 10/060009
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12505
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/575/07575743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060009 | Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells | Jan 29, 2002 | Issued |
| 09/913659 | Antisense modulation of phospholipase a2 group iv expression | Jan 27, 2002 | Abandoned |
| 09/913490 | Antisen modulation of smad4 expression | Jan 27, 2002 | Abandoned |
| 09/958289 | Antisense modulation of g-alpha-il expression | Jan 27, 2002 | Abandoned |
Array
(
[id] => 1174556
[patent_doc_number] => 06746844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-08
[patent_title] => 'Determining signal transduction pathways'
[patent_app_type] => B2
[patent_app_number] => 10/051020
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14837
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/746/06746844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051020 | Determining signal transduction pathways | Jan 21, 2002 | Issued |
Array
(
[id] => 6765560
[patent_doc_number] => 20030099959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Cooperative oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/054429
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9618
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054429 | Cooperative oligonucleotides | Jan 21, 2002 | Abandoned |
Array
(
[id] => 1085806
[patent_doc_number] => 06831072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'Compositions and methods of synthesis and use of novel nucleic acid structures'
[patent_app_type] => B2
[patent_app_number] => 10/055732
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 18212
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831072.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055732 | Compositions and methods of synthesis and use of novel nucleic acid structures | Jan 21, 2002 | Issued |
| 10/030404 | High specificity hairpin antisense oligonucleotides | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6693065
[patent_doc_number] => 20030040497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Compositions and methods for non-parenteral delivery of oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/029598
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30710
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029598 | Compositions and methods for non-parenteral delivery of oligonucleotides | Dec 20, 2001 | Issued |
